Jan Johannessen, a director at Twist Bioscience Corp (NASDAQ:TWST), executed sales of the company's common stock on May 12, 2026, according to a recent Form 4 filing with the SEC.
Mr. Johannessen sold 12,000 shares at $56.12 each, totaling $673,440. Simultaneously, he acquired 12,000 shares through employee stock options at $14.00 per share, worth $168,000.
The sale comes as Twist Bioscience shares surged 84% over the past year but currently trade at $52.95. Bond.az analysis suggests the stock is above its Fair Value. The company's beta of 2.23 indicates high volatility.
The options exercised were part of an employee stock option grant where one-third vested on October 30, 2019, with additional vesting annually.
Following these transactions, Mr. Johannessen directly holds 17,754 shares of Twist Bioscience common stock.
In other news, Twist Bioscience reported Q2 FY2026 earnings with revenue of $111 million, up 19% YoY, but an EPS miss at -$0.71. TD Cowen raised its price target from $58 to $68.
